CANTOR EQUITY PARTNERS I-A (CEPO) Fundamental Analysis & Valuation

NASDAQ:CEPO • KYG1827K1076

10.48 USD
0 (0%)
Last: Mar 5, 2026, 04:30 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CEPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, CEPO scores 1 out of 10 in our fundamental rating. CEPO was compared to 0 industry peers in the Unkown industry. The financial health of CEPO is average, but there are quite some concerns on its profitability. CEPO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. CEPO Profitability Analysis

1.1 Basic Checks

  • In the past year CEPO was profitable.
  • In the past year CEPO has reported a negative cash flow from operations.
CEPO Yearly Net Income VS EBIT VS OCF VS FCFCEPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20K -40K -60K -80K -100K

1.2 Ratios

Industry RankSector Rank
ROA 2%
ROE 2.01%
ROIC N/A
ROA(3y)-90.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CEPO Yearly ROA, ROE, ROICCEPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

  • CEPO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CEPO Yearly Profit, Operating, Gross MarginsCEPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CEPO Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CEPO has about the same amount of shares outstanding.
  • CEPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CEPO Yearly Shares OutstandingCEPO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
CEPO Yearly Total Debt VS Total AssetsCEPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50K 100K 150K 200K

2.2 Solvency

  • An Altman-Z score of 131.33 indicates that CEPO is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for CEPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 131.33
ROIC/WACCN/A
WACCN/A
CEPO Yearly LT Debt VS Equity VS FCFCEPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -50K -100K

2.3 Liquidity

  • CEPO has a Current Ratio of 0.36. This is a bad value and indicates that CEPO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CEPO has a Quick Ratio of 0.36. This is a bad value and indicates that CEPO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
CEPO Yearly Current Assets VS Current LiabilitesCEPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50K 100K 150K 200K 250K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CEPO Growth Analysis

3.1 Past

  • CEPO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3200.00%.
EPS 1Y (TTM)-3200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CEPO Valuation Analysis

4.1 Price/Earnings Ratio

  • CEPO is valuated quite expensively with a Price/Earnings ratio of 65.50.
  • Compared to an average S&P500 Price/Earnings ratio of 27.03, CEPO is valued quite expensively.
Industry RankSector Rank
PE 65.5
Fwd PE N/A
CEPO Price Earnings VS Forward Price EarningsCEPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEPO Per share dataCEPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CEPO Dividend Analysis

5.1 Amount

  • CEPO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CEPO Fundamentals: All Metrics, Ratios and Statistics

CANTOR EQUITY PARTNERS I-A

NASDAQ:CEPO (3/5/2026, 4:30:00 PM)

10.48

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14
Earnings (Next)03-16
Inst Owners80.99%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap267.24M
Revenue(TTM)N/A
Net Income(TTM)4.11M
AnalystsN/A
Price TargetN/A
Short Float %0.09%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 65.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB 1.31
EV/EBITDA N/A
EPS(TTM)0.16
EY1.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS8.02
TBVpS8.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.37
Profitability
Industry RankSector Rank
ROA 2%
ROE 2.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-90.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z 131.33
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2311.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CANTOR EQUITY PARTNERS I-A / CEPO FAQ

What is the ChartMill fundamental rating of CANTOR EQUITY PARTNERS I-A (CEPO) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CEPO.


What is the valuation status of CANTOR EQUITY PARTNERS I-A (CEPO) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANTOR EQUITY PARTNERS I-A (CEPO). This can be considered as Overvalued.


How profitable is CANTOR EQUITY PARTNERS I-A (CEPO) stock?

CANTOR EQUITY PARTNERS I-A (CEPO) has a profitability rating of 0 / 10.